CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 147 filers reported holding CONMED CORP in Q3 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $10,381,000 | +23.8% | 163,924 | -0.4% | 2.52% | -3.7% |
| Q4 2017 | $8,387,000 | -16.6% | 164,547 | -14.1% | 2.61% | -16.6% |
| Q3 2017 | $10,053,000 | -12.9% | 191,601 | -15.4% | 3.13% | -10.5% |
| Q2 2017 | $11,538,000 | -27.1% | 226,497 | -36.4% | 3.50% | -31.4% |
| Q1 2017 | $15,823,000 | +9.0% | 356,304 | +8.4% | 5.10% | -2.0% |
| Q4 2016 | $14,518,000 | +11.2% | 328,677 | +0.9% | 5.20% | +10.4% |
| Q3 2016 | $13,051,000 | -16.9% | 325,785 | -1.0% | 4.72% | -16.7% |
| Q2 2016 | $15,710,000 | +14.4% | 329,142 | +0.5% | 5.66% | +14.9% |
| Q1 2016 | $13,734,000 | -5.2% | 327,460 | -0.5% | 4.93% | +6.6% |
| Q4 2015 | $14,493,000 | +10.6% | 329,011 | +19.8% | 4.62% | -2.5% |
| Q3 2015 | $13,106,000 | -15.3% | 274,528 | +3.4% | 4.74% | -18.7% |
| Q2 2015 | $15,466,000 | +21.9% | 265,428 | +5.6% | 5.83% | +1.0% |
| Q1 2015 | $12,687,000 | +9.3% | 251,274 | -2.7% | 5.78% | -10.6% |
| Q4 2014 | $11,605,000 | – | 258,117 | – | 6.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |